London, Feb 10, 2026, 08:55 GMT — Regular session in progress.
- BAE Systems slipped roughly 0.7% soon after the open in London on Tuesday.
- The group landed a $137 million U.S. Army Foreign Military Sales contract to supply missile-warning equipment.
- BAE’s results land Feb. 18, and investors are watching for any guidance or hints on cash returns.
Shares of BAE Systems (BAES.L) slipped 0.7% to 1,930.0 pence by 0838 GMT on Tuesday, paring some of the gains logged in the prior session. Investors digested new U.S. defence contract headlines, while the stock itself has seen a strong run-up lately. 1
That retreat stands out: BAE’s been a go-to for investors tracking Western rearmament, but attention is shifting from the news cycle to earnings data. With results approaching, minor contract wins aren’t enough to budge the shares unless they alter the short-term picture.
In its November trading statement, BAE set Feb. 18 for the release of its preliminary results covering the year ended Dec. 31, 2025—a date now circled by investors looking to see where guidance, margins, and cash generation land. 2
BAE said late Monday it secured $137 million in Foreign Military Sales contracts with the U.S. Army, set to supply its AN/AAR-57 Common Missile Warning System—technology designed to detect and alert against missile threats. The Foreign Military Sales program handles U.S. government defense exports to partner countries. “International customers continue to choose CMWS for its proven effectiveness and reliability in combat,” said Jared Belinsky, director of Integrated Survivability Solutions at BAE Systems, in a statement. 3
The company disclosed in another filing that it acquired 114,829 shares on Feb. 6, set for cancellation under its current share buyback program. 4
BAE shares jumped 3.43% on Monday, ending the session at 19.44 pounds and leaving the FTSE 100’s smaller uptick behind, MarketWatch data showed. About 5 million shares changed hands—lighter than the 50-day average, per MarketWatch. 5
Tuesday’s early drop barely budged the stock out of its latest band. Investors remain keyed in on contract flow—still wondering if it’ll do more than just prop up what many see as an already lofty valuation, and actually feed into higher expectations.
The dynamic swings both directions. Sluggish order flow, program holdups, or softer cash conversion? Any of those could send the stock moving harder than the daily contract news implies—particularly after shares surged through February.
